Isaac Manke - 28 May 2025 Form 4 Insider Report for OnKure Therapeutics, Inc. (OKUR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
30 May 2025, 16:53:31 UTC
Prior SEC filing
02 Apr 2025
Next SEC filing
02 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Rogan Nunn, by power of attorney

Key filing fact

Isaac Manke filed Form 4 for OnKure Therapeutics, Inc. (OKUR) on 30 May 2025.

Key facts

  • This page summarizes Isaac Manke's Form 4 filing for OnKure Therapeutics, Inc. (OKUR).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 30 May 2025, 16:53.

Change

  • Previous filing in this sequence was filed on 02 Apr 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001622769 Primary reporting owner

Manke Isaac

Relationship
Director
Address
C/O ONKURE THERAPEUTICS, INC., 6707 WINCHESTER CIRCLE, SUITE 400, BOULDER
Signature
/s/ Rogan Nunn, by power of attorney
Signature date
30 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OKUR transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+7,650
Change %
Price
$0.000000
Shares after
7,650
Date
28 May 2025
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
7,650
Exercise price
$2.44
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

100% of the shares subject to the option will vest on the earlier of May 28, 2026 or the day prior to the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through the applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .